The joint pharmaceutical complexR-Opraorganized on the site Alabushevo of the special economic zone (SEZ) Technopolis Moscow will be engaged in industrial production of drugs of the hospital segment for the treatment of cardiac, oncologicaland psychiatric diseases, respiratory diseases, as well as multiple sclerosis and chronic renal failure.
The Ortat pharmaceutical plant, located in the village of Severnoye, is designed to produce finished dosage forms and high-tech packaging. Production projects of more than 10 leading pharmaceutical companies of the world are localized at this enterprise.
Pharmstandard manufactures medicines of various pharmacotherapeutic groups, including those for treatments of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological and infectious diseases, neurological disorders, metabolic disorders, oncology and a variety of other diseases.
New pharmaceutical facility located in Ryazan Oblast on a land plot of approximately 22 ha, with a total building area of 32 000 m², consisting of a production building with fractionation, purification and filling areas, classified clean rooms of A, B, C, D grades, air filtration and environmental monitoring in accordance with the sterile production requirements, a warehouse for storage of plasma, laboratories, an administrative building as well as auxiliary and utilities buildings.
The Yaroslavl plant of final dosage forms and biotechnological substances is a multifunctional site, the center of R-Pharm'sproduction and logistics operations in Russia. It produces different medicines, some of them under license agreements with the world's leading pharmaceutical companies.